Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Sickle cell disease (SCD), iNKT cells, and regadenoson infusion. [electronic resource] by
- Nathan, David G
- Field, Joshua
- Lin, Gene
- Neuberg, Donna
- Majerus, Elaine
- Onyekwere, Onyinye
- Keefer, Jeffrey
- Okam, Maureen
- Ross, Ainsley
- Linden, Joel
Producer: 20130701
In:
Transactions of the American Clinical and Climatological Association vol. 123
Availability: No items available.
|
|
5.
|
|
|
6.
|
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. [electronic resource] by
- Field, Joshua J
- Lin, Gene
- Okam, Maureen M
- Majerus, Elaine
- Keefer, Jeffrey
- Onyekwere, Onyinye
- Ross, Ainsley
- Campigotto, Federico
- Neuberg, Donna
- Linden, Joel
- Nathan, David G
Producer: 20130627
In:
Blood vol. 121
Availability: No items available.
|
|
7.
|
|
|
8.
|
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. [electronic resource] by
- Field, Joshua J
- Majerus, Elaine
- Gordeuk, Victor R
- Gowhari, Michel
- Hoppe, Carolyn
- Heeney, Matthew M
- Achebe, Maureen
- George, Alex
- Chu, Hillary
- Sheehan, Brian
- Puligandla, Maneka
- Neuberg, Donna
- Lin, Gene
- Linden, Joel
- Nathan, David G
Publication details: Blood advances Sep 2017
In:
Blood advances vol. 1
Availability: No items available.
|
|
9.
|
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment. [electronic resource] by
- Young, Arabella
- Ngiow, Shin Foong
- Gao, Yulong
- Patch, Ann-Marie
- Barkauskas, Deborah S
- Messaoudene, Meriem
- Lin, Gene
- Coudert, Jerome D
- Stannard, Kimberley A
- Zitvogel, Laurence
- Degli-Esposti, Mariapia A
- Vivier, Eric
- Waddell, Nicola
- Linden, Joel
- Huntington, Nicholas D
- Souza-Fonseca-Guimaraes, Fernando
- Smyth, Mark J
Producer: 20190123
In:
Cancer research vol. 78
Availability: No items available.
|